International Journal of Cardiovascular Research & Innovation

ABSTRACT

This review examines immune modulation as an innovative strategy for managing heart failure (HF), considering the shortcomings of conventional treatments in targeting inflammation that plays a critical role in Heart failure progression. Heart failure is increasingly acknowledged as being affected by chronic inflammation, which is fueled by cytokines and immune cell abnormalities, resulting in detrimental cardiac remodeling and compromised heart function. Emerging therapies aim to alleviate inflammation by focusing on pathways involving cytokines such as IL-1, IL-6, and TNF-α, as well as modulating immune cells like macrophages and T-cells. Combining these therapies with established Heart failure treatments and employing precision medicine for tailor-made strategies may lead to better outcomes and a transition toward individualized Heart failure care. Additional research is essential to fine-tune these strategies, ensuring effective immune modulation while preserving immune defense mechanisms.

Article History

Received 10 July 2024; Revised 01 August 2024; Accepted 08 August 2024

KEYWORDS

1. Heart failure treatment
2. Chronic inflammation
3. Personalized heart care
4. Macrophage and T-cell modulation